Julz is attending the Biotech Showcase Investor Forum held in San Francisco on January 13-15, 2019. The conference is an investor and networking event aiming to provide private and public biotechnology companies an opportunity to present to and to connect with investors and Pharma executives. The conference also features plenary sessions, workshops and one-to-one partnering sessions.

Julz is attending the RESI Conference in San Francisco on January 8th, 2019.

Dr Haroon will be the moderator of the “Investing in Personalized Medicine” panel. Please follow the link for more information.

Julz will be attending BioFIT Conference in Lille, France on Dec 4-5, 2018. BioFIT conferences are dedicated to bring academia and industry together. It has become the meeting point in Europe for tech transfer and for sourcing early-stage innovations stemming from public research institutions, academic spin-offs and emerging biotech companies. For more information, please visit BioFIT’s website.

Julz is attending the BIO Investor Forum Conference in San Francisco, CA on October 17-18, 2018.   The BIO Investor Forum is an international biotech investor conference focused on early and established private companies as well as emerging public companies. The event features various sessions such as business roundtables, company presentations and partnering meetings.

Julz Co is an investment management company focused on the health care industry with an emphasis on therapeutics, diagnostics, medical devices and digital healthcare. The company has offices in Chapel Hill, North Carolina, USA and Suzhou, China.  Julz typically invests in early stage biotechnology/medical device companies that have novel and proprietary technology addressing a vital market need and are driven by experienced management teams.

Julz is attending the RESI Conference in New York City on November 5th, 2018.

Julz Co is an investment management company focused on the health care industry with an emphasis on therapeutics, medical devices, digital healthcare and services. The company has offices in Chapel Hill, North Carolina, USA and Suzhou, China. Julz typically invests in early stage biotechnology/medical device companies that have novel and proprietary technology addressing a vital market need and are driven by experienced management teams.